{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:53:50Z","timestamp":1777438430647,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T00:00:00Z","timestamp":1374624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10456-013-9369-2","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T12:14:03Z","timestamp":1374668043000},"page":"963-973","source":"Crossref","is-referenced-by-count":23,"title":["Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma"],"prefix":"10.1007","volume":"16","author":[{"given":"Annunziata","family":"De Luisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Binetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Catacchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Racanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Pavone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Ribatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,24]]},"reference":[{"issue":"3","key":"9369_CR1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","volume":"87","author":"A Vacca","year":"1994","unstructured":"Vacca A, Ribatti D, Roncali L et al (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87(3):503\u2013508","journal-title":"Br J Haematol"},{"issue":"1","key":"9369_CR2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.leu.2404402","volume":"21","author":"D Ribatti","year":"2007","unstructured":"Ribatti D, Nico B, Crivellato E, Roccaro AM, Vacca A (2007) The history of the angiogenic switch concept. Leukemia 21(1):44\u201352","journal-title":"Leukemia"},{"issue":"2","key":"9369_CR3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.leu.2404067","volume":"20","author":"A Vacca","year":"2006","unstructured":"Vacca A, Ribatti D (2006) Bone marrow angiogenesis in multiple myeloma. Leukemia 20(2):193\u2013199","journal-title":"Leukemia"},{"issue":"31","key":"9369_CR4","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/sj.onc.1209456","volume":"25","author":"D Ribatti","year":"2006","unstructured":"Ribatti D, Nico B, Vacca A (2006) Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25(31):4257\u20134266","journal-title":"Oncogene"},{"issue":"5","key":"9369_CR5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.onc.1210691","volume":"27","author":"C Scavelli","year":"2008","unstructured":"Scavelli C, Nico B, Cirulli T et al (2008) Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene 27(5):663\u2013674","journal-title":"Oncogene"},{"key":"9369_CR6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-12-394310-1.00005-9","volume":"299","author":"D Ribatti","year":"2012","unstructured":"Ribatti D (2012) Angiogenic effects of erythropoietin. Int Rev Cell Mol Biol 299:199\u2013234","journal-title":"Int Rev Cell Mol Biol"},{"issue":"11","key":"9369_CR7","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3324\/haematol.2010.025015","volume":"95","author":"L Lifshitz","year":"2010","unstructured":"Lifshitz L, Tabak G, Gassmann M, Mittelman M, Neumann D (2010) Macrophages as a novel target for erythropoietin. Haematologica 95(11):1823\u20131831","journal-title":"Haematologica"},{"issue":"9","key":"9369_CR8","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1182\/blood-2003-04-1338","volume":"102","author":"A Vacca","year":"2003","unstructured":"Vacca A, Ria R, Semeraro F et al (2003) Endothelial cells in the bone marrow of patients with multiple myeloma. Blood 102(9):3340\u20133348","journal-title":"Blood"},{"issue":"2","key":"9369_CR9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ejca.2009.10.019","volume":"46","author":"M Moschetta","year":"2010","unstructured":"Moschetta M, Di Pietro G, Ria R et al (2010) Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma. Eur J Cancer 46(2):420\u2013429","journal-title":"Eur J Cancer"},{"issue":"7","key":"9369_CR10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/1078-0432.CCR-10-2381","volume":"17","author":"A Luisi De","year":"2011","unstructured":"De Luisi A, Ferrucci A, Coluccia AML et al (2011) Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma. Clin Cancer Res 17(7):1935\u20131946","journal-title":"Clin Cancer Res"},{"issue":"4","key":"9369_CR11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"issue":"1","key":"9369_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nprot.2006.13","volume":"1","author":"D Ribatti","year":"2006","unstructured":"Ribatti D, Nico B, Vacca A, Presta M (2006) The gelatin sponge-chorioallantoic membrane assay. Nat Protoc 1(1):85\u201391","journal-title":"Nat Protoc"},{"key":"9369_CR13","first-page":"163","volume":"6","author":"S Elliott","year":"2012","unstructured":"Elliott S, Sinclair AM (2012) The effect of erythropoietin on normal and neoplastic cells. Biologics 6:163\u2013189","journal-title":"Biologics"},{"issue":"8","key":"9369_CR14","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V93.8.2627","volume":"93","author":"D Ribatti","year":"1999","unstructured":"Ribatti D, Presta M, Vacca A et al (1999) Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93(8):2627\u20132636","journal-title":"Blood"},{"issue":"4","key":"9369_CR15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2002-11-3422","volume":"102","author":"N Perelman","year":"2003","unstructured":"Perelman N, Selvaraj SK, Batra S et al (2003) Placenta growth factor activates monocytes and correlates with sickle disease severity. Blood 102(4):1506\u20131514","journal-title":"Blood"},{"issue":"9","key":"9369_CR16","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1593\/neo.08140","volume":"10","author":"T Okazaki","year":"2008","unstructured":"Okazaki T, Ebihara S, Asada M, Yamanda S, Niu K, Arai H (2008) Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis. Neoplasia 10(9):932\u2013939","journal-title":"Neoplasia"},{"issue":"19","key":"9369_CR17","first-page":"6162","volume":"63","author":"KL Blackwell","year":"2003","unstructured":"Blackwell KL, Kirkpatrick JP, Snyder SA et al (2003) Human recombinant erythropoietin significantly improves tumor oxygenation independent of its effects on hemoglobin. Cancer Res 63(19):6162\u20136165","journal-title":"Cancer Res"},{"issue":"6","key":"9369_CR18","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1371\/journal.pone.0000549","volume":"2","author":"ME Hardee","year":"2007","unstructured":"Hardee ME, Cao Y, Fu P et al (2007) Erythropietin blockade inhibits the induction of tumor angiogenesis and progression. PLoS ONE 2(6):e549","journal-title":"PLoS ONE"},{"issue":"1","key":"9369_CR19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm.2575","volume":"18","author":"Y Xue","year":"2011","unstructured":"Xue Y, Lim S, Yang Y et al (2011) PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells. Nat Med 18(1):100\u2013110","journal-title":"Nat Med"},{"issue":"3","key":"9369_CR20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2559.2003.01581.x","volume":"42","author":"D Ribatti","year":"2003","unstructured":"Ribatti D, Marzullo A, Nico B, Crivellato E, Ria R, Vacca A (2003) Erytropoietin is an angiogenic factor in gastric carcinoma. Histopathology 42(3):246\u2013250","journal-title":"Histopathology"},{"issue":"5","key":"9369_CR21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2559.2007.02654.x","volume":"50","author":"D Ribatti","year":"2007","unstructured":"Ribatti D, Marzullo A, Gentile A et al (2007) Erytropoietin\/erytropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma. Histopathology 50(5):591\u2013596","journal-title":"Histopathology"},{"issue":"5","key":"9369_CR22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2559.2007.02653.x","volume":"50","author":"D Ribatti","year":"2007","unstructured":"Ribatti D, Poliani PL, Longo V, Mangieri D, Nico B, Vacca A (2007) Erythropoietin\/erythropoietin-receptor system is involved in angiogenesis in human neuroblastoma. Histopathology 50(5):636\u2013641","journal-title":"Histopathology"},{"issue":"6","key":"9369_CR23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2613.2010.00731.x","volume":"91","author":"D Ribatti","year":"2010","unstructured":"Ribatti D, Nico B, Perra MT et al (2010) Erytropoietin is involved in angiogenesis in human primary melanoma. Int J Exp Pathol 91(6):495\u2013499","journal-title":"Int J Exp Pathol"},{"issue":"1","key":"9369_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11060-010-0294-6","volume":"102","author":"B Nico","year":"2011","unstructured":"Nico B, Annese T, Guidolin D, Finato N, Crivellato E, Ribatti D (2011) Epo is involved in angiogenesis in human glioma. J Neurooncol 102(1):51\u201358","journal-title":"J Neurooncol"},{"issue":"4","key":"9369_CR25","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3892\/ijo.2011.1261","volume":"40","author":"J Yang","year":"2012","unstructured":"Yang J, Xiao Z, Li T, Gu X, Fan B (2012) Erytropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis. Int J Oncol 40(4):1230\u20131237","journal-title":"Int J Oncol"},{"issue":"5","key":"9369_CR26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1469-7580.2009.01131.x","volume":"215","author":"D Ribatti","year":"2009","unstructured":"Ribatti D, Crivellato E, Nico B, Guidolin D, Gassmann M, Djonov V (2009) Mast cells and macrophages in duodenal mucosa of mice overexpressing erythropoietin. J Anat 215(5):548\u2013554","journal-title":"J Anat"},{"issue":"2","key":"9369_CR27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1182\/blood-2006-12-063602","volume":"110","author":"A Bogdanova","year":"2007","unstructured":"Bogdanova A, Mihov D, Lutz H, Saam B, Gassmann M, Vogel J (2007) Enhanced erythro-phagocytosis in polycythemic mice overexpressing erythropoietin. Blood 110(2):762\u2013769","journal-title":"Blood"},{"issue":"3","key":"9369_CR28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0002-9440(10)63459-1","volume":"163","author":"ZA Haroon","year":"2003","unstructured":"Haroon ZA, Amin K, Jiang X, Arcasoy MO (2003) A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol 163(3):993\u20131000","journal-title":"Am J Pathol"},{"issue":"857","key":"9369_CR29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/pgmj.73.857.163","volume":"73","author":"A Olujihungle","year":"1997","unstructured":"Olujihungle A, Handa S, Holmes J (1997) Does erythropoietin accelerate malignant transformation in multiple myeloma? Postgrad Med J 73(857):163\u2013164","journal-title":"Postgrad Med J"},{"issue":"12","key":"9369_CR30","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1182\/blood.V98.12.3492","volume":"98","author":"U Bunworasate","year":"2001","unstructured":"Bunworasate U, Arnouk H, Minderman H et al (2001) Erythopoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia. Blood 98(12):3492\u20133494","journal-title":"Blood"},{"issue":"4","key":"9369_CR31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000203625","volume":"98","author":"M Mittelman","year":"1997","unstructured":"Mittelman M, Zeidman A, Fradin Z, Magazanik A, Lewinski UH, Cohen A (1997) Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia. Acta Haematol 98(4):204\u2013210","journal-title":"Acta Haematol"},{"issue":"9","key":"9369_CR32","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1073\/pnas.081275298","volume":"98","author":"M Mittelman","year":"2001","unstructured":"Mittelman M, Neumann D, Peled A, Kanter P, Haran-Ghera N (2001) Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proc Natl Acad Sci USA 98(9):5181\u20135186","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"9369_CR33","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2141.2006.06366.x","volume":"135","author":"S Prutchi-Sagiv","year":"2006","unstructured":"Prutchi-Sagiv S, Golishevsky N, Oster HS et al (2006) Erytropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease? Br J Haematol 135(5):660\u2013672","journal-title":"Br J Haematol"},{"issue":"3","key":"9369_CR34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000087896","volume":"114","author":"O Katz","year":"2005","unstructured":"Katz O, Barzilay E, Skaat A, Herman A, Mittelman M, Neumann D (2005) Erytropoietin induced tumor mass reduction in murine lymphoproliferative models. Acta Haematol 114(3):177\u2013179","journal-title":"Acta Haematol"},{"issue":"6","key":"9369_CR35","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/eji.200637025","volume":"37","author":"O Katz","year":"2007","unstructured":"Katz O, Gil L, Lifshitz L et al (2007) Erytropoietin enhances immune responses in mice. Eur J Immunol 37(6):1584\u20131593","journal-title":"Eur J Immunol"},{"issue":"8","key":"9369_CR36","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(03)01163-X","volume":"4","author":"B Leyland-Jones","year":"2003","unstructured":"Leyland-Jones B (2003) Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 4(8):459\u2013460","journal-title":"Lancet Oncol"},{"issue":"9402","key":"9369_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(03)15189-6","volume":"363","author":"T Powles","year":"2004","unstructured":"Powles T, Shamash J, Liu W (2004) Erytropoietin to treat anemia in patients with head and neck cancer. Lancet 363(9402):82","journal-title":"Lancet"},{"issue":"4","key":"9369_CR38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tem.2012.10.007","volume":"24","author":"Y Cao","year":"2013","unstructured":"Cao Y (2013) Erytropoietin in cancer: a dilemma in risk therapy. Trends Endocrinol Metab 24(4):190\u2013199","journal-title":"Trends Endocrinol Metab"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-013-9369-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-013-9369-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-013-9369-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T13:52:25Z","timestamp":1596203545000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-013-9369-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,24]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9369"],"URL":"https:\/\/doi.org\/10.1007\/s10456-013-9369-2","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,24]]}}}